Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Cefdinir close to filing in U.S.

April 19, 1996

New patent issued to Interferon Sciences

April 12, 1996

Anti-HSV compound karalicin

April 12, 1996

Dutch approval for Amphocil

April 12, 1996

S-28679, a new interferon biosynthesis inducer from 3M

April 12, 1996

AmBisome approved for marketing in Spain

April 12, 1996

Mentax approvable for athlete's foot

April 12, 1996

New antifungals isolated from actinomycetes at Schering-Plough

April 12, 1996

L-742728 selected by Merck & Co. for further evaluation

April 12, 1996

Virend entering phase III

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 1, 2025.
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Marks’ departure intensifies regulatory uncertainty at US FDA
BioWorld
Peter Marks’ March 28 letter giving one week’s notice of his resignation as director of the U.S. FDA’s Center for Biologics Evaluation and Research (CBER) is...